Skip to main content

Clinical trial ANITA

A phase II multicenter study comparing the efficacy of the oral angiogenesis inhibitor nintedanib with the intravenous cytotoxic compound ifosfamide for treatment of patients with advanced metastatic soft tissue sarcoma after failure of systemic non-oxazaphosphorine-based first line chemotherapy for inoperable disease

Organ Multiple
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor EORTC
EudraCT Identifier 2016-002093-12
Inclusion criteria second line metastatic
Last update